GMP News
Most Popular GMP Story
Walloped with $26M in fines, KV closes ETHEX
A combination of multimillion-dollar GMP-violation fines and the likely loss of government contracts have brought the ETHEX generic drug unit of KV Pharmaceutical to the end of the road. KV says it... Read more...
Latest Headlines
- March 18, 2010
- March 1, 2010
- February 17, 2010
- February 1, 2010
- January 26, 2010
- December 22, 2009
- November 12, 2009
- November 11, 2009
- November 11, 2009
- November 10, 2009
- October 13, 2009
- September 8, 2009
- August 24, 2009
- August 18, 2009
- August 4, 2009
- July 22, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
